Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
Noosa News19 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General22 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
General23 hours agoPM kicks off roundtable with call for lasting reform
-
Noosa News20 hours agoMan dead after breaking into childcare centre